27
Participants
Start Date
May 31, 2006
Primary Completion Date
April 30, 2007
Study Completion Date
May 31, 2007
TroVax
11 Intramuscular injection of TroVax® over 45 weeks. A single dose of 5 x 108 pfu/ml, will be given by an intramuscular injection into the deltoid muscle of the upper arm.
GM-CSF
168 subcutaneous GM-CSF injections over 45 weeks. Administered every day as a subcutaneous injection at a dose of 250mcg/m2/d (maximum 500 mcg) in weeks 1 and 2 of each 28 day cycle (total of 14 days per cycle with a total of 12 cycles).
The Methodist Hospital Research Institute, Houston
Collaborators (1)
Oxford BioMedica
INDUSTRY
The Methodist Hospital Research Institute
OTHER